Institutional investors purchased a net $4.5 million shares of ONVO during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 13.92% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARGENTA BANQUE D'EPARGNE SA Bought 34.2 Thousand shares of Organovo Holdings Inc
HIGHVALUE PARTNERS AG Bought 1.9 Thousand shares of Organovo Holdings Inc
BECK CAPITAL MANAGEMENT LLC Sold 2.9 Thousand shares of Organovo Holdings Inc